Member Registration | Non-Member Registration |  Press Registration 

One of the leading sectors of high tech investment in startups, following the burst of the bubble, has been the medical device sector. The number of IPO's has grown dramatically from 2004 and the number of acquisitions by a large players such as J&J and Guidant also grown significantly. Devices for new types of stents, measurement devices for blood oxygen or blood glucose sugar, surgical devices and many others are being developed by new startups in the hope of achieving major successes and profitable exists. What is unique about investment in medical devices? What issues are specific to the success or failure of medical device startups? (e.g. regulatory issues, insurance reimbursement, etc.). What are the promising opportunities in medical devices? What are the growth segments in the market?, What are the longer term prospects for such investments? IPO Vs. M&A, what’s the right strategy?
These and other questions will be discussed, success stories and failures will be shared and debates will be encouraged.

February 13, 2007
5:30PM -9:30PM
KPMG, Mountain View
5:30PM-6:30PM Poster Sessions/ Buffet Dinner/ Networking
6:30PM-7:30PM Startup Company Presentations / Q & A
7:30PM-8:00PM Break
8:00PM-9:00PM Panel Discussion
Topic: "The Future of Medical Devices: Innovations, Market Growth and Exit Models"
9:00PM-9:30PM Discussion

Moderator: Gerald Jay Sanders, Managing Director ,San Francisco ScienceTM


Gerald Jay Sanders

Gerald Jay (“Jerry”) Sanders is a guest faculty member (Entrepreneurship) at Oxford University’s Saïd Business School (“Associate Fellow”) and an advisor and lecturer at the Paris Chamber of Commerce and Industry and at its affiliated business school, Advancia. The Jerry Sanders Case, a popular Harvard Business School “Entrepreneurship” case, is taught as part of the MBA program at Harvard, Oxford, Stanford, Kellogg (Northwestern), and MIT. Jerry has an extensive background in medical technology incubation, development and international cooperation. As President of the Shaw Group and later as Managing Director of his own San Francisco Science Group, Sanders has acquired and developed medical devices in the United States, Germany, Argentina, Israel and the Former Soviet Republics. He has sold companies and partnered with industry giants, among them Boston Scientific, Johnson & Johnson, Abbot and Baxter.

Panelist: Dana Mead, Partner, Kleiner Perkins Caufield & Byers


Dana Mead

For the past 23 years, Dana's career has focused on identifying new medical technologies. He has worked with physician thought leaders around the world representing 10 different medical specialties. At KPCB, Dana leverages experience gained from his venture-funded, start-up management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting disease. Prior to joining KPCB, Dana was President of Guidant Vascular Intervention, a fully integrated billion dollar division with over 4500 employees. Since joining Guidant, he held positions as Vice President and General Manager, Cardiac & Vascular Surgery; Vice President and General Manager, Stents, Vascular Intervention Group; President, Japan and A/P Operations based in Tokyo; and Vice President, Corporate Relations and Policy with responsibility for investor relations, corporate communications, corporate marketing and public policy initiatives. Prior to joining Guidant, Dana worked in various sales and marketing roles at Allergan, Inc. and Johnson & Johnson. Dana serves on the boards of the California Healthcare Institute (CHI), the Cardiovascular Research Foundation (CRF), AesThera, Inc., Sonitus, Amigo Therapy, OtisMed Corporation and Lucille Packard Children's Hospital (LPCH).
Panelist: Scott J. Wolf, M.D. Partner, Prospect Venture Partners


Scott J. Wolf

Prior to joining Prospect, Scott was a Vice-President at Frazier Healthcare Ventures, where he was involved in medical device investments across all stages from seed to commercialization. While at Frazier, Scott founded and served as CEO and Director of Juniper Medical, a device startup developing non-invasive methods of bodysculpting and cellulite therapy, and Primaeva, a startup developing devices for aesthetic procedures. Prior to joining Frazier, Scott was a founding partner of Scout Medical Technologies, a venture capital incubator developing new medical device companies. While at Scout, Scott co-founded three portfolio companies: Cardiac Dimensions, Archus Orthopedics, and Endogastric Solutions. Prior to Scout, Scott was President of Itasca Ventures, a medical device incubator funded by Medtronic, where he was involved in founding a number of companies. Scott currently serves on the Board of Directors of Cabochon Aesthetics and is a Board Observer on Kythera Biopharmaceuticals. Scott is an inventor on numerous issued and pending patents in the medical device field. He received his M.D. from George Washington University and his B.A. from the University of Pennsylvania.
Panelist: Vance Vanier, Partner, Mohr Davidow Ventures

Vance Vanier

Vance Vanier brings to MDV a diverse blend of healthcare, industry, and international experiences. He focuses on life science and online health investments. In addition to investing, Vance also works to develop MDV's life science companies serving in virtual CMO and business development roles. He is a member of the clinical faculty in the Division of Emergency Medicine at Stanford Medical Center. He received an M.D. from the Johns Hopkins School of Medicine and did his residency training at UCSF and Highland Hospital. Prior to joining MDV he received an MBA from Stanford University, worked in corporate development at Nektar Therapeutics, and traveled to Kosovo after the war to work with the WHO in creating the nation's first ambulance system. Vance did his undergraduate work at Stanford where he received dual bachelor's degrees with honors.
Panelist: Jay Watkins, Managing Director , De Novo Ventures


Jay Watkins

Mr. Watkins was a co-founder of Origin Medsystems, a venture funded medical technology start-up that was purchased by Eli Lilly & Company in 1992. When Eli Lilly divested its medical device businesses to form Guidant in 1995, he became a member of the corporation's management committee, serving in this role from 1995-2002. During this time, he served as president of numerous divisions, including the Minimally Invasive Surgery Group. In addition, Mr. Watkins was the President of Compass, Guidant Corporation's corporate business development and new ventures group. Prior to founding Origin, Mr. Watkins held management positions in several start-ups, including Microgenics Corporation, and was a consultant with the international consulting firm of McKinsey & Company. He has been a member of the board of directors of several public companies, including Gynecare, Cardiogenesis, and Rita Medical. Jay also serves on the Stanford University School of Engineering Advisory Council. Mr. Watkins received his MBA from Harvard Business School and his undergraduate degree from Stanford University.
Poster Session Companies
Media Partner

Members RSVP

Guests Registration

To view a complete list of participating companies click here.

Press Registration


 Companies that would like to participate please click here.
Copyrights 2007 Silicom Ventures LLC. All Rights Reserved